Markets Shrug Off Semi Weakness…And One Biopharma Stock Surges After Trial Results 6/24/24
CNBC's "Fast Money"
00:00
Analysis of the healthcare sector and a biopharma stock surge
The chapter delves into the uncertainties surrounding the healthcare industry, emphasizing political influences like drug pricing and regulations that can impact the sector. It also touches on a significant advancement in heart disease treatment that boosted the stock value of a biopharmaceutical company.
Play episode from 29:15
Transcript
